je.st
news
Health care's big deal
2014-11-29 01:33:46| Biotech - Topix.net
Scientist Janet Lineberger does research for Merck & Co. in February 2013. Merck agreed in June to pay nearly $4 billion for Idenix Pharmaceuticals Inc. to combine its hepatitis C medicines with its own.
Tags: health
big
deal
cares
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|